TruSkin®: Study for the Treatment of Chronic Diabetic Foot Ulcers
NCT02936115 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 14
Last updated 2017-04-06
Summary
The purpose of this study is to compare the clinical outcomes of TruSkin® and an Active Comparator in patients with chronic diabetic foot ulcers.
Conditions
- Diabetic Foot Ulcers
Interventions
- OTHER
-
TruSkin®
- OTHER
-
Wound Cover
Sponsors & Collaborators
-
Osiris Therapeutics
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-07-31
- Primary Completion
- 2017-04-30
- Completion
- 2017-04-30
Countries
- United States
Study Locations
More Related Trials
-
A Prospective Trial of Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AC
NCT06511596 ·Status: COMPLETED ·Phase: NA
-
Diabetic Foot Ulcers-Comparing Transforming Powder to Standard of Care
NCT05046158 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers
NCT00312364 ·Status: COMPLETED ·Phase: PHASE2
-
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
NCT01596920 ·Status: COMPLETED ·Phase: PHASE4
-
GrafixPRIME® for the Treatment of Chronic Diabetic Foot Ulcers
NCT02675855 ·Status: COMPLETED ·Phase: PHASE4
-
Omega3 Wound Fish Skin Graft in the Treatment of DFUs
NCT04133493 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy and Safety Study of Dermal-Living Skin Replacement to Treat Diabetic Foot Ulcers
NCT00368693 ·Status: TERMINATED ·Phase: PHASE3
-
Nu-3 Gel for Infected Diabetic Foot Ulcers
NCT06020235 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Santyl Applications to Diabetic Foot Ulcers
NCT02111291 ·Status: COMPLETED ·Phase: PHASE4
-
Pivotal Trial of Dermagraft(R) to Treat Diabetic Foot Ulcers
NCT01181453 ·Status: COMPLETED ·Phase: PHASE3
-
Mirragen Diabetic Foot Ulcer Study
NCT06598241 ·Status: RECRUITING
-
Study of Oasis Ultra in Diabetic Foot Ulcers
NCT01835379 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
NCT02352480 ·Status: UNKNOWN ·Phase: NA
-
Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers
NCT01830348 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Subjects With Diabetic Foot Ulcer (DFU)
NCT03153007 ·Status: COMPLETED
-
Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers
NCT00926068 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
NCT06826339 ·Status: RECRUITING ·Phase: PHASE4
-
Phase 2a Multi-Center Prospective, Randomized Trial to Evaluate the Safety & Efficacy of Topical PEP-TISSEEL for Diabetic Foot Ulcers (DFU)
NCT06319287 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial to Examine Effectiveness of a Human Allograft for Treatment of DFU and VLU
NCT03999281 ·Status: COMPLETED
-
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
NCT02326337 ·Status: COMPLETED ·Phase: NA
-
A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers
NCT03078933 ·Status: UNKNOWN ·Phase: NA
-
Bioresorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers
NCT06403605 ·Status: COMPLETED ·Phase: NA
-
A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot Ulcers
NCT06852976 ·Status: RECRUITING ·Phase: PHASE2
-
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
NCT06455475 ·Status: RECRUITING ·Phase: NA
-
Efficacy of TR 987, Beta-1,3-1,6-D-glucan, in the Treatment of Chronic Venous Insufficiency Ulcers
NCT03154619 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2